MYC amplification in metastatic prostate cancer associated with reduced tumor immunogenicity
“MYC amplification is associated with reduced tumor immunogenicity as assessed by the recovery of IR recombination reads from prostate cancer genomics files”
2026-03-11
(Press-News.org)
“MYC amplification is associated with reduced tumor immunogenicity as assessed by the recovery of IR recombination reads from prostate cancer genomics files.”
BUFFALO, NY — March 11, 2026 — A new research paper was published in Volume 13 of Oncoscience on February 7, 2026, titled “Reduced immunogenicity of MYC amplified, metastatic prostate cancer.”
Led by Sunny Kahlon of the Department of Molecular Medicine, Morsani College of Medicine, University of South Florida — with corresponding author George Blanck (also affiliated with the Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute) — the study uses a genomics-based approach to test whether MYC copy-number amplification in prostate tumors is linked to clinical outcomes and to tumor immunogenicity as inferred from adaptive immune receptor (IR) recombination reads recovered from sequencing files.
Using TCGA-PRAD and multiple metastatic prostate cancer datasets (including WCDT-MCRPC and CMI-MPC), the authors quantified MYC copy numbers and then measured recovery of adaptive IR recombination reads (IGH, IGK, IGL for B cells; TRA, TRB, TRG, TRD for T cells) from tumor RNAseq and whole-genome sequence files. They found that MYC amplification was more frequent in metastatic disease and associated with worse progression-free survival. Importantly, MYC-amplified metastatic tumors yielded significantly fewer recovered adaptive IR recombination reads and showed reduced expression of immune-marker gene sets, consistent with reduced tumor immunogenicity — with the reduction most pronounced for B-cell–related reads.
“The above findings reveal a correlation of increased MYC amplification with metastatic stages of prostate cancer. And, the MYC amplification is associated with poorer PFS outcomes and reduced immunogenicity, particularly in the MYC-amplified metastatic tumors.”
The authors stress that these results derive from computational mining of existing genomics files and that confirmatory immune-repertoire measurements (for example, PCR-based assays) and prospective clinical sampling will strengthen the conclusions. Nevertheless, the pattern reported — MYC amplification linked to both aggressive disease and a quantitatively reduced adaptive immune footprint — suggests that MYC status could be an important biomarker for prognosis and for predicting which metastatic prostate cancers are unlikely to respond to immune checkpoint blockade alone. The authors propose that strategies to restore T-cell (or B-cell) infiltration or function might re-sensitize MYC-amplified tumors to immunotherapy.
DOI: https://doi.org/10.18632/oncoscience.644
Correspondence to: George Blanck – gblanck@usf.edu
Abstract video: https://www.youtube.com/watch?v=9iWjrHoA9qA
Keywords: cancer, prostate cancer, MYC amplification, adaptive immune receptor recombinations, reduced immunogenicity, RNAseq files
Click here to sign up for free Altmetric alerts about this article.
About Oncoscience:
Oncoscienceis a peer-reviewed, open-access, traditional journal covering the rapidly growing field of cancer research, especially emergent topics not currently covered by other journals. This journal has a special mission: freeing oncology from publication costs. It is free to readers and authors.
Oncoscience is indexed and archived by PubMed, PubMed Central, Scopus, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).
To learn more about Oncoscience, visit Oncoscience.us and connect with us on social media:
X
Instagram
Facebook
YouTube
LinkedIn
For media inquiries, please contact media@impactjournals.com.
END
ELSE PRESS RELEASES FROM THIS DATE:
2026-03-11
We become forgetful as we age. This is often seen as a universal truth, but in fact it is far from universal: some people remain incredibly sharp at 100 years old, while others experience memory loss starting in middle age.
While it seems logical that age-related cognitive decline would be blamed on brain aging and degeneration (which, like anything in the brain, is notoriously hard to treat), there’s some evidence that processes elsewhere in the body influence the brain’s ability to form memories. In particular, neuronal pathways that sense the status of other organs in the body can influence cognitive functions in the brain. Other studies ...
2026-03-11
The sight of a delectable plate of lasagna or the aroma of a holiday ham are sure to get hungry bellies rumbling in anticipation of a feast to come. But although we’ve all experienced the sensation of “eating” with our eyes and noses before food meets mouth, much less is known about the information superhighway, known as the vagus nerve, that sends signals in the opposite direction — from your gut straight to your brain.
These signals relay more than just what you’ve eaten ...
2026-03-11
CINCINNATI—A multi-center study led by researchers at Cincinnati Children’s sheds surprising new light on why some newborns become severely ill from Escherichia coli infection, but others do not.
Turns out that most babies are immune because of germ-fighting antibodies they receive from their moms.
The study, published March 11, 2026, in the prestigious journal Nature, dove into new depths to explore why only some babies develop severe infection to common bacteria. E. coli is a common bacteria that lives in the intestines of ...
2026-03-11
How One Flu Virus Can Hamper the Immune Response to Another
Prior exposure to one strain of influenza virus may weaken children’s ability to mount an effective antibody response against their subsequent exposure to a different flu strain, according to a study led by Weill Cornell Medicine investigators. The analysis of the pediatric response to H3N2 and H1N1 influenza A viruses, two of the most common causes of flu, provides insight into the concept of “immune imprinting,” and supports ...
2026-03-11
New research published today in Nature finds that tumor cells within supratentorial ependymomas (SE) – an aggressive childhood brain cancer – cluster into distinct tumor cell populations. Much like a neighborhood in your hometown, each cell subtype within these “communities” has a specific (and previously unappreciated) role to play. Understanding how SE tumor cells form neighborhoods and the function of each cell type could help better predict how these tumor cell subtypes will respond to treatment.
The research team, led by Mariella Filbin, MD, PhD, Co-Director of the Brain Tumor Center at Dana Farber/Boston Children’s Cancer ...
2026-03-11
Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient’s cells. However, most genetic disorders are caused by dozens or even thousands of unique mutations spread across a gene; this diversity results in challenges of scale when it comes to developing customized therapies for many individuals. A more universal strategy could involve the precise insertion of an entire copy of a healthy gene into a specific location in the genome, which could, in principle, provide a single, widely applicable treatment for all patients irrespective of their mutation ...
2026-03-11
Astronomers have for the first time seen the birth of a magnetar — a highly magnetized, spinning neutron star — and confirmed that it’s the power source behind some of the brightest exploding stars in the cosmos.
The finding corroborates a theory proposed by a UC Berkeley physicist 16 years ago and establishes a new phenomenon in exploding stars: supernovae with a “chirp” in their light curve that is caused by general relativity. A paper describing the phenomenon was published today ...
2026-03-11
CAMBRIDGE, MA -- Photonic chips use light to process data instead of electricity, enabling faster communication speeds and greater bandwidth. Most of that light typically stays on the chip, trapped in optical wires, and is difficult to transmit to the outside world in an efficient manner.
If a lot of light could be rapidly and precisely beamed off the chip, free from the confines of the wiring, it could open the door to higher-resolution displays, smaller Lidar systems, more precise 3D printers, or larger-scale quantum computers.
Now, researchers from MIT and elsewhere have developed a new class ...
2026-03-11
(Santa Barbara, Calif.) — For decades, astronomers have used distant supernovae as cosmic lighthouses to test fundamental physics and to measure the universe. For Joseph Farah, a fifth-year graduate student at UC Santa Barbara, one particular supernova began to signal something never seen before: a “chirp.”
In a groundbreaking paper accepted to the journal Nature, Farah and a team of international researchers, including his advisor Andy Howell, who leads the supernova group at Las Cumbres Observatory (LCO), announce the discovery of a superluminous supernova (SN 2024afav) whose erratic behavior has confirmed a long-standing theory ...
2026-03-11
Coral reefs are being hit hard by the climate crisis, and timely interventions for their survival are a top priority. The Global Coral Tech Transfer Project enables SECORE International and the Australian Institute of Marine Science (AIMS) to implement the latest scientifically developed coral breeding techniques on a large scale across regions. The practical implementation of the project is carried out jointly and in close cooperation with Dominican Republic-based partner FUNDEMAR, combining Australian technology, Caribbean coral breeding science, and in-depth experience in implementing restoration efforts successfully. ...
LAST 30 PRESS RELEASES:
[Press-News.org] MYC amplification in metastatic prostate cancer associated with reduced tumor immunogenicity
“MYC amplification is associated with reduced tumor immunogenicity as assessed by the recovery of IR recombination reads from prostate cancer genomics files”
